Royal London Asset Management Ltd. bought a new position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 309,412 shares of the real estate investment trust's stock, valued at approximately $7,076,000.
Other hedge funds also recently bought and sold shares of the company. Thrivent Financial for Lutherans purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at $1,880,000. Swedbank AB purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at $1,832,000. Associated Banc Corp purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at $10,559,000. Pathstone Holdings LLC purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at $1,968,000. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at $9,361,000. Hedge funds and other institutional investors own 93.57% of the company's stock.
Healthpeak Properties Price Performance
Shares of NYSE:DOC traded up $0.30 during trading on Monday, reaching $21.68. 2,325,139 shares of the company's stock traded hands, compared to its average volume of 5,654,493. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93. The firm has a market cap of $15.16 billion, a PE ratio of 45.49, a P/E/G ratio of 2.38 and a beta of 1.13. The company has a 50-day simple moving average of $22.07 and a 200-day simple moving average of $21.30.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 EPS for the quarter, missing analysts' consensus estimates of $0.44 by ($0.32). Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The business had revenue of $700.40 million for the quarter, compared to analyst estimates of $682.51 million. During the same quarter last year, the business earned $0.45 earnings per share. Healthpeak Properties's revenue was up 25.9% on a year-over-year basis. As a group, analysts predict that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current year.
Healthpeak Properties Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.54%. The ex-dividend date was Monday, November 4th. Healthpeak Properties's dividend payout ratio (DPR) is presently 255.32%.
Analyst Ratings Changes
Several analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a "hold" rating to a "buy" rating and increased their price objective for the company from $20.00 to $28.00 in a report on Monday, October 21st. Mizuho cut their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating on the stock in a research report on Thursday. Citigroup upped their target price on Healthpeak Properties from $20.00 to $22.00 and gave the company a "neutral" rating in a research report on Thursday, August 22nd. Evercore ISI upped their target price on Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a research report on Monday, September 16th. Finally, Scotiabank upped their target price on Healthpeak Properties from $23.00 to $24.00 and gave the company a "sector outperform" rating in a research report on Monday, September 9th. One analyst has rated the stock with a sell rating, five have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Healthpeak Properties presently has a consensus rating of "Moderate Buy" and an average target price of $23.00.
View Our Latest Stock Report on DOC
About Healthpeak Properties
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Further Reading
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
